Malin Hultqvist Hopkins
CEO
Member of the board
Redoxis AB
Sweden
Biography
Dr. Malin Hultqvist Hopkins is since May 2016 CEO of Redoxis. Malin holds a PhD in Medical Inflammation Research from Lund University (Sweden) and was between 2009-2016 CSO of Redoxis and director of CRO services. Malin is also member of the board of Redoxis subsidiary ProNoxis AB, focusing on development of small molecule drugs for treatment of autoimmune conditions.
Research Interest
Medical Inflammation
